Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale – parent form

Gau, Susan Shur‐Fen; Shang, Chi-Yung; Liu, Shih-Kai; Lin, Chia Wei; Swanson, James M.; Liu, Yu-Chih; Tu, Changling

doi:10.1002/mpr.237

Cited by 270 publications

(237 citation statements)

References 35 publications

Supporting

Mentioning

231

Contrasting

Order By: Relevance

“…The key instrument used to determine the effectiveness outcome was the Chinese version of SNAP-IV that consisted of 18 ADHD items and 8 ODD items. Each item was scored for severity on a four-point Likert scale (0-3: 0 = not at all to 3 = very much) (Swan 1995;Gau et al 2008b). …”

Section: Methodsmentioning

confidence: 99%

Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate

Chou

Chen²,

Chen³

et al. 2012

Journal of Child and Adolescent Psychopharmacology

View full text Add to dashboard Cite

Objectives: The purpose of this study was to identify the optimal dose of osmotic release oral system methylphenidate (OROS-MPH) using a dosage forced-titration scheme to achieve symptomatic remission in children with attention-deficit/ hyperactivity disorder (ADHD). We also evaluated the efficacy and safety of, and patient and parent satisfaction with, the change in therapy from immediate-release methylphenidate (IR-MPH) to OROS-MPH over 10 weeks. Method: We recruited 521 children and adolescents aged 6-18 years with an American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) diagnosis of ADHD, who had received IR-MPH treatments ( < 70 mg/ day) for at least 1 month. The treatment, switched from IR-MPH to OROS-MPH according to a conversion scheme, started with a 6-week forced-titration phase of OROS-MPH to achieve symptomatic remission (defined as a score of 0 or 1 for each of the first 18 ADHD items in the Chinese version of the Swanson, Nolan, and Pelham, Version IV [SNAP-IV]), followed by a 4-week maintenance phase. The global ADHD severity and drug side effects of the participants were evaluated. Parents completed the ratings scales for the ADHD-related symptoms. Patient and parent satisfaction for the OROS-MPH treatment was also assessed. Results: Among the 439 participants with ADHD who completed the trial, 290 participants (66.1%) achieved symptomatic remission. The mean dose of OROS-MPH among participants in remission was 36.7 mg (1.08 mg/kg) per day. Increased efficacy, superior satisfaction, and safety equivalent to that of IR-MPH were demonstrated in intra-individual comparisons from the baseline to the end of study. Determinants for remission included less severe ADHD symptoms (SNAP-IV score < 40), no family history of ADHD, and an appropriate dosage of medication according to the patient's weight. Conclusions: The findings suggest remission as a treatment goal for ADHD therapy by providing an optimal dosage of medication for children and adolescents with ADHD through using an effective and tolerable forced-titration scheme.

show abstract

Section: Methodsmentioning

confidence: 99%

Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate

Chou

Chen²,

Chen³

et al. 2012

Journal of Child and Adolescent Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…In this study, we used the Chinese version of the SNAP-26 questionnaire (30). It consists of the Diagnostic and Statistical Manual of Mental Disorders-IV symptoms for the inattention (Items 1-9) and hyperactivity/impulsivity (Items 10-18) criteria for ADHD and the oppositional symptom (Item 19-26) criteria for ODD.…”

Section: Evaluation Of Adhd and Oddmentioning

confidence: 99%

Associations between allergic diseases and attention deficit hyperactivity/oppositional defiant disorders in children

et al. 2016

Self Cite

View full text Add to dashboard Cite

Background:We aim to investigate the detailed associations between allergic diseases with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) among children. Methods: Clinical information from 2,896 children enrolled in the Taiwan Children Health Study was obtained for analyses. Allergic diseases, including atopic dermatitis, asthma, and allergic rhinitis, have been evaluated based on the questions adjusted from International Study of Asthma and Allergies in Childhood. The Swanson, Nolan, and Pelham questionnaire was used to assess symptoms of ADHD and ODD. Symptoms of depression, stress, and poor sleep quality were evaluated as the interactive risk factors. results: Children having symptoms of allergic diseases within the past 1 y were associated with having all dimensions of symptoms of ADHD and ODD. Children with ever having a physician-diagnosed atopic dermatitis were associated with inattentive and hyperactive-impulsive symptoms of ADHD. Ever diagnosed asthma was associated with ADHD and ODD. Ever diagnosed allergic rhinitis was associated with inattentive and combined symptoms of ADHD and ODD. conclusion: Children with allergic diseases, such as atopic dermatitis, asthma, and allergic rhinitis, were associated with exhibiting ADHD and ODD.

show abstract

“…Children aged 6-18 years who had received a diagnosis of ADHD on the basis of the diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision [29] between November 2010 and October 2012 were invited to participate in the study. ADHD was diagnosed on the basis of multiple data sources, including (a) an interview with a child psychiatrist, (b) clinical observation of the participant's behavior, and (c) history provided by the mother and the results of the short Chinese version of the Swanson, Nolan, and Pelham Scale, Version IV (SNAP-IV) [30,31]. We interviewed with children and their parents to collect their histories of development and school adjustment and performance.…”

Section: Participantsmentioning

confidence: 99%

“…The short version of the SNAP-IV-Chinese version was used to assess the severity of the mother-Research Cheng-Fang Yen reported DSM-IV-TR-derived inattention, hyperactivity-impulsivity, and oppositional symptoms in the month preceding the present study [30,31]. Each item is rated on a 4-point Likert scale, ranging from 0 (not at all) to 3 (very much).…”

Section: Adhd and Oppositional Symptomsmentioning

confidence: 99%

Relationships of Subjective Insomnia and Sleep Duration with Depression, Anxiety, and Pain Problems in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Wang¹,

Wu²,

Yang³

et al. 2018

Neuropsychiatry

View full text Add to dashboard Cite

Objective:This study examined the relationships of subjective insomnia and short and long nocturnal sleep duration with depression, anxiety, and pain problems in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Methods:A total of 469 children and adolescents (97 girls and 372 boys; age, 6-18 years) who had received a clinical diagnosis of ADHD completed the eight-item Athens Insomnia Scale, Children's Depression Inventory-Taiwan Version, Multidimensional Anxiety Scale for ChildrenTaiwanese Version, and a questionnaire about sleep duration, pain-related dysfunction, and the severity of perceived pain. Their parents provided information on the children's current ADHD and oppositional symptoms, rated on the abridged Chinese version of the Swanson, Nolan, and Pelham Scale, Version IV. Multiple regression was conducted to examine the relationships of subjective insomnia and sleep duration with depression and anxiety. Logistic regression was applied to examine the relationships of subjective insomnia and sleep duration with pain-related dysfunction and the severity of perceived pain. Results:Subjective insomnia was positively associated with depression, anxiety, pain-related dysfunction, and severe perceived pain in the study population. Short nocturnal sleep duration was positively associated with depression, anxiety, and perceived pain. Long nocturnal sleep duration was positively associated with anxiety and perceived pain. Conclusion:Insomnia and short and long nocturnal sleep duration are associated with depression, Neuropsychiatry (London) (2018) 8(1) 139Research Cheng-Fang Yen Sleep problems not only have negative impacts on quality of life and social functioning [16] but are also significantly associated with health problems. Previous cross-sectional studies have indicated that youth with comorbid ADHD and depression [17] and anxiety may have sleep problems that are more severe relative to those with ADHD alone [18,19]. Prospective studies have shown that sleep problems can significantly predict greater depressive but not anxiety symptoms 1 year later in young adolescents with ADHD [20], that transient or persistent sleep problems at the baseline can predict behavioral and emotional problems 1 year later in children with ADHD [21], and that sleep problems at the baseline can predict emotional problems at 6 months (and vice versa) [22]. These results indicate that sleep problems should be a treatment target for depression and anxiety symptoms in individuals with ADHD.Several issues concerning the association of insomnia and sleep duration with health problems in individuals with ADHD warrant further study. First, community-based studies have shown that compared with adolescents with average sleep duration, those with long nocturnal sleep duration were more prone to violence, alcohol and illicit drug use, and truancy [23], whereas long nocturnal sleep duration was found to be significantly associated with higher psychological well-being and quality of life [24]. Although one...

show abstract

Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale – parent form

Cited by 270 publications

References 35 publications

Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate

Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate

Associations between allergic diseases and attention deficit hyperactivity/oppositional defiant disorders in children

Relationships of Subjective Insomnia and Sleep Duration with Depression, Anxiety, and Pain Problems in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Contact Info

Product

Resources

About